Click a link below to view the mailing archive as if it had been sent to you.
| 2017-05-31 12:15 | | Teva posts positive phase 3 migraine data, plots FDA submission and more... |
| 2017-05-31 00:15 | | Johnson & Johnson commits $990M to land Protagonist’s oral Crohn’s drug and more... |
| 2017-05-30 12:15 | | Prepping for ASCO? Investor Brad Loncar offers his own breakdown of what to watch for and more... |
| 2017-05-30 00:15 | | Two Red Hot Biotechs With Big Near-term Catalysts Ahead and more... |
| 2017-05-29 12:15 | | [video]FDA to publish list of drugs with no generic competitor and more... |
| 2017-05-26 12:15 | | Here's How the FDA Just Helped Trump Deliver on a Big Promise and more... |
| 2017-05-25 12:15 | | Accelerated FDA approval and pricey drugs make a rotten combo, doctors argue and more... |
| 2017-05-24 12:15 | | Pioneering Merck makes another breakthrough with PD-1 star Keytruda, grabbing first OK for a cancer biomarker and more... |
| 2017-05-23 12:15 | | Trump Budget Contains Little on Drug Prices Despite Tough Talk and more... |
| 2017-05-23 00:15 | | Nevada bill could force Sanofi, Novo and Lilly to reveal their insulin pricing secrets and more... |
| 2017-05-22 12:15 | | FDA review raises some serious questions for Puma, but shares rocket up on positive notes and more... |
| 2017-05-21 00:15 | | Pharma’s Identity Crisis: Four strategies for creating value in life sciences and more... |
| 2017-05-19 12:15 | | 7 Areas to watch from the ASCO abstracts and more... |
| 2017-05-19 00:15 | | High Court Won’t Hear Dispute Challenging FDA Over J&J Drug and more... |
| 2017-05-18 12:15 | | New Study Says 63% of US Adults Trust FDA and more... |
| 2017-05-17 12:15 | | J&J, steering through a rough patch, draws blockbuster roadmap with 11 new meds and more... |
| 2017-05-17 00:15 | | FDA Adds Boxed Warning to Janssen's Type 2 Diabetes Drug Label and more... |
| 2017-05-16 12:15 | | Editas loses its lead in the biotech race to launch the first CRISPR/Cas9 human study and more... |
| 2017-05-16 00:15 | | Novartis, slammed by Korean scandal, tweaks its ethics, compliance policies and more... |
| 2017-05-15 12:15 | | Pharma's Not So Stingy With R&D After All and more... |
| 2017-05-15 00:15 | | Horizon dives into eye treatments with River Visions acquisition |
| 2017-05-13 12:15 | | WHO Officials Offer Opposition to Value-Based Drug Pricing and more... |
| 2017-05-12 12:15 | | Sanofi is a 'satisfactory' business with no urgent M&A needs, chairman says and more... |
| 2017-05-12 00:15 | | How Big Pharma Might Be Cut Down To Size and more... |
| 2017-05-11 12:15 | | Glaxo scores again as FDA strikes down would-be Advair copycats Hikma, Vectura and more... |
| 2017-05-10 12:15 | | New study points to a double-digit hike in branded drug prices, spotlighting a growing national debate and more... |
| 2017-05-10 00:15 | | GlaxoSmithKline looks for Breo boost with landmark real-world asthma study and more... |
| 2017-05-09 12:15 | | Trump's Pick to Lead FDA Has Backing of Big Pharma and more... |
| 2017-05-09 00:15 | | Horizon Pharma buys River Vision and its fast-tracked eye med for $145M and more... |
| 2017-05-08 12:15 | | Just what Sanofi and Regeneron wanted: A Dupixent rollout so zippy, it's fueling bigger sales forecasts and more... |
| 2017-05-07 12:15 | | Troubled Teva’s successor to Copaxone just failed a big PhIII test for multiple sclerosis and more... |
| 2017-05-05 12:15 | | House Votes To Repeal Obamacare And The Real Fight Begins and more... |
| 2017-05-05 00:15 | | Novartis continues its blitz on NASH deals, grabbing an exclusive tie-up in race to develop cocktails and more... |
| 2017-05-04 12:15 | | Doctors with restricted sales-rep access prescribed fewer promoted meds: JAMA and more... |
| 2017-05-04 00:15 | | Shire conservative as it navigates Baxalta integration and more... |
| 2017-05-03 12:15 | | Look out, Glaxo: Advair is Express Scripts' next big cost-savings target and more... |
| 2017-05-02 12:15 | | Pfizer beats 1Q profit forecasts, but sales dip misses views and more... |
| 2017-05-01 12:15 | | 3 Big Drugmakers That Could Make Billions Under Trump's Tax Plan and more... |
| 2017-05-01 00:15 | | 5 Big Drugmakers With Important Catalysts in May and more... |
